FDA approves Baxter's hemophilia B therapy; Randal Kirk invests in AmpliPhi;

@FierceBiotech: Big Data guru Atul Butte's NuMedii scores $3.5M VC round for 'digital' drug research. FierceBiotech IT story | Follow @FierceBiotech

 @JohnCFierce: Stanley Family Foundation spearheads a $21M round for Heptares - (GPCRs). News | Follow @JohnCFierce

@RyanMFierce: J&J's pharma chairman lands 'more deals' in Boston innovation push. Report | Follow @RyanMFierce

> Baxter International announced that the FDA has approved Rixubis [Coagulation Factor IX (Recombinant)] for adults with hemophilia B. Release

> AmpliPhi BioSciences raised $7 million from a private placement of shares. The biotech is working on antibacterial therapies to treat drug resistant infections. Randal Kirk's Third Security was one of the investors. Release

> Seattle Genetics ($SGEN) has exercised an option to co-develop an additional antibody-drug conjugate under a collaboration deal it has with Agensys. Release

Pharma News

@FiercePharma: India suspends Actos on safety concerns. Two other (very old) drugs, too. Report | Follow @FiercePharma

@EricPFierce: FDA goes from passive to aggressive on compounders. I wonder how long before certain Congressmen complain. More | Follow @EricPFierce

@CarlyHFierce: Proxy fight heating up at Vivus... First Manhattan announces search for new CEO candidates. Yesterday's story | Follow @CarlyHFierce

> Pfizer, Amgen eye $1B deal for Russian biosimilars developer Biocad. Report

> Novo Nordisk steps away from now-controversial Paula Deen. Article

> Aspen feeds its global appetite with 2nd deal in a week. News

Medical Device News

@FierceMedDev: St. Jude takes to Japan with MRI-safe pacer. Story | Follow @FierceMedDev

@DamianFierce: For CROs big and small, you're only as good as your reputation. The view from  DIA 2013. Editor's corner | Follow @DamianFierce

@MichaelGFierce: SEC hammers imaging company, CEO with fraud charges. Report | Follow @MichaelGFierce

> Medtronic warns over pump tied to 14 deaths. Story

> Navidea keys up Alzheimer's Dx agent for Phase III. News

Pharma Manufacturing News

> Aspen, Merck deal includes API plants in U.S., Netherlands. Article

> Roche sets out strict expectations for contractors. Report

> Drugmakers more concerned with quality than price in picking CMOs. Item

> FDA spells out its expectations for crude heparin. More

Vaccines News

> Japan faces vaccine shortage in struggle to control rubella. Report

> ACIP rules on GSK, Novartis and Sanofi vaccines. Story

> Corruption alleged as Indian vaccine shortage continues. Item

> Type 1 diabetes vaccine impresses in early study. News

> Takeda tackling norovirus in bid to grow vaccine biz. Article

And Finally… A new study helps explain how parts of the brain maintain their balance of zinc, an element required in small but crucial doses. Release